Cargando…

Carriers and Antigens: New Developments in Glycoconjugate Vaccines

Glycoconjugate vaccines have proven their worth in the protection and prevention of infectious diseases. The introduction of the Haemophilus influenzae type b vaccine is the prime example, followed by other glycoconjugate vaccines. Glycoconjugate vaccines consist of two components: the carrier prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Put, Robert M.F., Metz, Bernard, Pieters, Roland J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962112/ https://www.ncbi.nlm.nih.gov/pubmed/36851097 http://dx.doi.org/10.3390/vaccines11020219

Ejemplares similares

Protein Carriers for Glycoconjugate Vaccines: History, Selection Criteria, Characterization and New Trends
por: Micoli, Francesca, et al.
Publicado: (2018)

Validation of an FFF-MALS Method to Characterize the Production and Functionalization of Outer-Membrane Vesicles for Conjugate Vaccines
por: van der Put, Robert M. F., et al.
Publicado: (2022)

Recent Advances in the Synthesis of Glycoconjugates for Vaccine Development
por: Colombo, Cinzia, et al.
Publicado: (2018)

A new type of glycoconjugate vaccine containing Klebsiella fimbriae type 1 and 3 as carrier proteins
por: Witkowska, D, et al.
Publicado: (1997)

GMMA as an Alternative Carrier for a Glycoconjugate Vaccine against Group A Streptococcus
por: Palmieri, Elena, et al.
Publicado: (2022)

Impact and Control of Sugar Size in Glycoconjugate Vaccines
por: Stefanetti, Giuseppe, et al.
Publicado: (2022)

Pyruvate Substitutions on Glycoconjugates
por: Hager, Fiona F., et al.
Publicado: (2019)

Recent advances in the production of recombinant glycoconjugate vaccines
por: Kay, Emily, et al.
Publicado: (2019)

Editorial: Glycoconjugates in vaccines and immunotherapeutics
por: Shivatare, Sachin, et al.
Publicado: (2022)

Recent advances on smart glycoconjugate vaccines in infections and cancer
por: Anderluh, Marko, et al.
Publicado: (2021)

Potential targets for next generation antimicrobial glycoconjugate vaccines
por: Micoli, Francesca, et al.
Publicado: (2018)

Recent and Future Advances in the Chemoenzymatic Synthesis of Homogeneous Glycans for Bacterial Glycoconjugate Vaccine Development
por: Adegbite, Ayobami, et al.
Publicado: (2021)

Glycoconjugate vaccines: classic and novel approaches
por: Adamo, Roberto
Publicado: (2021)

Recent Advances in Toll Like Receptor-Targeting Glycoconjugate Vaccines
por: Li, Qingjiang, et al.
Publicado: (2018)

Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
por: Morais, Victor, et al.
Publicado: (2022)

Retaining the structural integrity of disulfide bonds in diphtheria toxoid carrier protein is crucial for the effectiveness of glycoconjugate vaccine candidates
por: Carboni, Filippo, et al.
Publicado: (2022)

Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
por: Stefanetti, G., et al.
Publicado: (2020)

Classical and novel strategies to develop a Shigella glycoconjugate vaccine: from concept to efficacy in human
por: Barel, Louis-Antoine, et al.
Publicado: (2019)

Glycoconjugation: An approach to cancer therapeutics
por: Molejon, Maria I, et al.
Publicado: (2020)

Glycoconjugate Vaccines for Prevention of Haemophilus influenzae Type b Diseases
por: Khatuntseva, E. A., et al.
Publicado: (2021)

Sugar–Protein Connectivity Impacts on the Immunogenicity of Site-Selective Salmonella O-Antigen Glycoconjugate Vaccines
por: Stefanetti, Giuseppe, et al.
Publicado: (2015)

Multicomponent polysaccharide–protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates
por: Méndez, Yanira, et al.
Publicado: (2018)

Expanding polysaccharide–protein coupling of glycoconjugate vaccines
por: Berti, Francesco
Publicado: (2022)

Development of an automated platform for the optimal production of glycoconjugate vaccines expressed in Escherichia coli
por: Samaras, Jasmin J., et al.
Publicado: (2021)

Cytoplasmic glycoengineering of Apx toxin fragments in the development of Actinobacillus pleuropneumoniae glycoconjugate vaccines
por: Passmore, Ian J., et al.
Publicado: (2019)

Progress towards a glycoconjugate vaccine against Group A Streptococcus
por: Burns, Keira, et al.
Publicado: (2023)

Recent Advances in the Chemistry of Glycoconjugate Amphiphiles
por: Latxague, Laurent, et al.
Publicado: (2018)

Sterol and Sphingoid Glycoconjugates from Microalgae
por: Stonik, Valentin A., et al.
Publicado: (2018)

Strain Selection for Generation of O-Antigen-Based Glycoconjugate Vaccines against Invasive Nontyphoidal Salmonella Disease
por: Lanzilao, Luisa, et al.
Publicado: (2015)

Monitoring antigenic protein integrity during glycoconjugate vaccine synthesis using capillary electrophoresis-mass spectrometry
por: Tengattini, Sara, et al.
Publicado: (2016)

Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to Francisella tularensis
por: Stefanetti, Giuseppe, et al.
Publicado: (2019)

The role of glycoconjugates as receptors for insecticidal proteins
por: Best, Hannah L, et al.
Publicado: (2023)

Preparation of aminoethyl glycosides for glycoconjugation
por: Šardzík, Robert, et al.
Publicado: (2010)

Harnessing galactose oxidase in the development of a chemoenzymatic platform for glycoconjugate vaccine design
por: Duke, Jeremy A., et al.
Publicado: (2021)

Immunogenicity Assessment of Different Segments and Domains of Group a Streptococcal C5a Peptidase and Their Application Potential as Carrier Protein for Glycoconjugate Vaccine Development
por: Wang, Guirong, et al.
Publicado: (2021)

Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines
por: Anish, Chakkumkal, et al.
Publicado: (2021)

Malabaricane and Isomalabaricane Triterpenoids, Including Their Glycoconjugated Forms
por: Stonik, Valentin A., et al.
Publicado: (2021)

The glycoconjugate ontology (GlycoCoO) for standardizing the annotation of glycoconjugate data and its application
por: Yamada, Issaku, et al.
Publicado: (2021)

Development of an Efficacious, Semisynthetic Glycoconjugate Vaccine Candidate against Streptococcus pneumoniae Serotype 1
por: Schumann, Benjamin, et al.
Publicado: (2018)

Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa
por: Baliban, Scott M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_inj5nbsou4fqmaftgkl70l6pb6